R Najera

Summary

Affiliation: Instituto de Salud Carlos III
Country: Spain

Publications

  1. ncbi request reprint Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay
    M L Villahermosa
    Centro Nacional Biologia Fundamental, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    J Hum Virol 4:238-48. 2001
  2. ncbi request reprint Genetic recombination and its role in the development of the HIV-1 pandemic
    Rafael Najera
    Department of Viral Patogénesis, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    AIDS 16:S3-16. 2002
  3. ncbi request reprint Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients
    R Carmona
    Area de Patogenia Viral, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    J Clin Virol 32:248-53. 2005
  4. ncbi request reprint Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union
    E Vazquez de Parga
    Instituto de Salud Carlos III, Madrid, Spain
    J Med Virol 77:337-44. 2005
  5. ncbi request reprint Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1
    L Perez-Alvarez
    Area de Patogenia Viral, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    J Med Virol 78:141-7. 2006
  6. doi request reprint Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections
    A Fernandez-Garcia
    Viral Pathogenesis Department, CNM, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    AIDS Res Hum Retroviruses 25:93-102. 2009

Collaborators

  • E Delgado
  • L M Frenkel
  • Michael M Thomson
  • L Perez-Alvarez
  • G Contreras
  • R Carmona
  • E Vazquez de Parga
  • L Medrano
  • A Fernandez-Garcia
  • A Ocampo
  • M Pinilla
  • M Sierra
  • M Munoz
  • M T Cuevas
  • G Casado
  • Y Vega
  • S Osmanov
  • M L Villahermosa
  • V Garcia
  • M Muñoz-Nieto
  • E Serrano-Bengoechea
  • M González-Galeano
  • M J Lezaun
  • A Asorey
  • C Miralles
  • S Pérez de Castro
  • J A Taboada
  • A Vinogradova
  • A Rakhmanova
  • I Beck
  • E V de Parga
  • N Manjon

Detail Information

Publications6

  1. ncbi request reprint Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay
    M L Villahermosa
    Centro Nacional Biologia Fundamental, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    J Hum Virol 4:238-48. 2001
    ..To develop an assay for the early detection and quantification of minor human immunodeficiency virus-1 populations bearing multiple drug resistance (MDR) mutations...
  2. ncbi request reprint Genetic recombination and its role in the development of the HIV-1 pandemic
    Rafael Najera
    Department of Viral Patogénesis, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    AIDS 16:S3-16. 2002
  3. ncbi request reprint Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients
    R Carmona
    Area de Patogenia Viral, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    J Clin Virol 32:248-53. 2005
    ....
  4. ncbi request reprint Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union
    E Vazquez de Parga
    Instituto de Salud Carlos III, Madrid, Spain
    J Med Virol 77:337-44. 2005
    ..These data underline the importance of genotypic resistance testing of chronically HIV-1-infected patients before initiating treatment, in order to select the most suitable drug regimen...
  5. ncbi request reprint Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1
    L Perez-Alvarez
    Area de Patogenia Viral, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    J Med Virol 78:141-7. 2006
    ....
  6. doi request reprint Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections
    A Fernandez-Garcia
    Viral Pathogenesis Department, CNM, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    AIDS Res Hum Retroviruses 25:93-102. 2009
    ..Near full-length genome characterization may be necessary for evaluating clade-specific reactivities...